Cong Claire Xu insider trades
Open-market stock purchases and sales by Cong Claire Xu, EVP, Clinical Development at NovaBridge Biosciences, from SEC Form 4 filings since May 30, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | NBP NovaBridge Biosciences | Sold | $2.6K |
| Aug 30, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
| Aug 30, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
| Jul 6, 2026 | NBP NovaBridge Biosciences | Sold | $4K |
| Jul 4, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
| Jul 4, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
| Jun 1, 2026 | NBP NovaBridge Biosciences | Sold | $13.8K |
| May 30, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
| May 30, 2026 | NBP NovaBridge Biosciences | Bought (not open market) | — |
Companies traded
- NBP NovaBridge Biosciences: 3 sales, last Aug 31, 2026